N.M. Stat. § 26-4-2

Current through 2024, ch. 69

Section 26-4-2 - Definitions

As used in the Wholesale Prescription Drug Importation Act:

A. "Canadian supplier" means a manufacturer, wholesale distributor or pharmacy that is appropriately licensed or permitted under Canadian federal or provincial laws and rules to manufacture, distribute or dispense prescription drugs;

B. "committee" means the prescription drug importation advisory committee;

C. "department" or "authority" means the health care authority department;

D. "eligible prescription drug" means a drug eligible for importation that:

(1) meets the United States food and drug administration's standards related to safety, effectiveness, misbranding and adulteration;

(2) does not violate federal patent laws;

(3) is expected to generate cost savings; and

(4) is not a controlled substance;

E. "program" means the wholesale prescription drug importation program; and

F. "state drug wholesaler" means a licensed wholesale drug distributor that contracts with the state to import eligible prescription drugs from a Canadian supplier.

NMS § 26-4-2

Laws 2020, ch. 45, § 2.

Amended by 2024, c. 39,s. 58, eff. 7/1/2024.